Whoever invents a coronavirus vaccine will control the patent – and, importantly, who gets to use it
- Written by Natalie Stoianoff, Professor, Faculty of Law, University of Technology Sydney
With research laboratories around the world racing to develop a coronavirus vaccine, a unique challenge has emerged: how to balance intellectual property rights with serving the public good.
Questions of patent protection and access to those patents has prompted an international group of scientists and lawyers to...